Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Alzheimer    crawled date : 2021 - 11 - 11    save search

Eisai Presents New Analysis Of Lecanemab Clinical Efficacy Results From Phase 2b Study At Clinical Trials On Alzheimer's Disease (CTAD) Conference
Published: 2021-11-11 (Crawled : 20:00) - biospace.com/
BIIB | $191.63 -0.28% 170K twitter stocktwits trandingview |
Health Technology
| | O: -0.12% H: 0.37% C: -0.02%

disease alzheimer ema phase 2 clinical trials results trials phase 2b trial conference alzheimer’s alzheimer's disease alzheimer's lecanemab
New Blood Test To Identify People At Risk Of Developing Alzheimer's Symptoms Will Be Used In Clinical Trial Aiming To Prevent Memory Loss
Published: 2021-11-11 (Crawled : 15:00) - biospace.com/
BIIB | $191.63 -0.28% 170K twitter stocktwits trandingview |
Health Technology
| | O: -0.12% H: 0.37% C: -0.02%

alzheimer blood risk test trial alzheimer’s alzheimer's
Gainers vs Losers
80% 20%

Top 10 Gainers
TIRX | $1.13 133.09% 44M twitter stocktwits trandingview |

AGBA | $0.8978 124.45% 60M twitter stocktwits trandingview |
Finance

BPTH | $6.18 90.74% 39M twitter stocktwits trandingview |
Health Technology

INVO | $1.44 89.47% 3M twitter stocktwits trandingview |
Health Technology

XPON | $2.66 37.82% 5.2M twitter stocktwits trandingview |

SINT | $0.0504 35.12% 300M twitter stocktwits trandingview |
Health Technology

THCH | $1.38 32.69% 9.9M twitter stocktwits trandingview |
n/a

ALRN | $5.605 31.88% 210K twitter stocktwits trandingview |
Health Technology

HOLO | $2.92 30.36% 22M twitter stocktwits trandingview |

MLEC | $1.8 27.66% 2.1M twitter stocktwits trandingview |
n/a


Your saved searches
Save your searches and get alerts when important news are released.